CCK-8 assays were used to assess cellular viability to investigate the effect of GPX4 on the proliferation of thyroid cancer cells, and the results showed that GPX4 knockdown markedly decreased FTC133 cell viability (Figure 5C). This evidence concerns the gene GPX4 and thyroid cancer.